Fairfield, Bush & Co’s Merck MRK Stock Holding History

Fairfield, Bush & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.56M	Sell	21,247 -1,247	-6%	-$144K	1.42%	22
2025 Q4	$2.37M	Sell	22,494 -563	-2%	-$52.8K	1.25%	24
2025 Q3	$1.94M	Buy	23,057 +3,969	+21%	+$327K	0.99%	30
2025 Q2	$1.51M	Buy	19,088 +1,988	+12%	+$158K	0.85%	33
2025 Q1	$1.53M	Buy	17,100 +4,679	+38%	+$437K	0.97%	32
2024 Q4	$1.24M	Buy	12,421 +1,235	+11%	+$127K	0.73%	41
2024 Q3	$1.27M	Sell	11,186 -580	-5%	-$68.9K	0.76%	39
2024 Q2	$1.46M	Sell	11,766 -216	-2%	-$27.8K	0.87%	33
2024 Q1	$1.58M	Sell	11,982 -295	-2%	-$36.4K	0.94%	33
2023 Q4	$1.34M	Sell	12,277 -870	-7%	-$90.3K	0.78%	35
2023 Q3	$1.35M	Sell	13,147 -10,375	-44%	-$1.12M	0.88%	32
2023 Q2	$2.71M	Buy	23,522 +127	+0.5%	+$14.4K	0.75%	31
2023 Q1	$2.49M	Buy	23,395 +10,284	+78%	+$1.11M	0.88%	32
2022 Q4	$1.45M	Buy	13,111 +38	+0.3%	+$3.88K	0.96%	27
2022 Q3	$1.13M	Sell	13,073 -901	-6%	-$80.4K	0.8%	37
2022 Q2	$1.27M	Sell	13,974 -2,684	-16%	-$238K	0.75%	34
2022 Q1	$1.37M	Sell	16,658 -937	-5%	-$73.9K	0.69%	37
2021 Q4	$1.35M	Sell	17,595 -16,124	-48%	-$1.28M	0.65%	40
2021 Q3	$2.53M	Sell	33,719 -6,765	-17%	-$515K	0.82%	36
2021 Q2	$3.15M	Sell	40,484 -3,452	-8%	-$257K	0.86%	37
2021 Q1	$3.23M	Sell	43,936 -731	-2%	-$53.9K	0.92%	31
2020 Q4	$3.49M	Buy	44,667 +218	+0.5%	+$16.7K	1.02%	31
2020 Q3	$3.52M	Buy	44,449 +105	+0.2%	+$8.22K	1.12%	24
2020 Q2	$3.27M	Buy	44,344 +22,003	+98%	+$1.66M	1.17%	26
2020 Q1	$1.64M	Buy	22,341 +2,672	+14%	+$210K	0.68%	38
2019 Q4	$1.71M	Buy	19,669 +1,834	+10%	+$151K	0.63%	42
2019 Q3	$1.43M	Buy	17,835 +577	+3%	+$46.2K	0.5%	49
2019 Q2	$1.38M	Buy	17,258 +2,305	+15%	+$176K	0.47%	50
2019 Q1	$1.19M	Buy	14,953 +2,096	+16%	+$157K	0.39%	54
2018 Q4	$937K	Sell	12,857 -326	-2%	-$23K	0.32%	63
2018 Q3	$892K	Sell	13,183 -581	-4%	-$37K	0.25%	81
2018 Q2	$797K	Sell	13,764 -372	-3%	-$21K	0.23%	79
2018 Q1	$735K	Buy	14,136 +422	+3%	+$22.8K	0.21%	85
2017 Q4	$736K	Buy	13,714 +326	+2%	+$18.1K	0.2%	81
2017 Q3	$818K	Hold	13,388	–	–	0.26%	75
2017 Q2	$819K	Sell	13,388 -367	-3%	-$22.3K	0.26%	68
2017 Q1	$834K	Hold	13,755	–	–	0.26%	65
2016 Q4	$773K	Hold	13,755	–	–	0.25%	69
2016 Q3	$819K	Sell	13,755 -210	-2%	-$12.3K	0.27%	65
2016 Q2	$768K	Sell	13,965 -209	-1%	-$11.1K	0.27%	62
2016 Q1	$716K	Sell	14,174 -1,101	-7%	-$53.9K	0.26%	64
2015 Q4	$770K	Buy	15,275 +9,831	+181%	+$496K	0.27%	69
2015 Q3	$257K	Sell	5,444 -14,298	-72%	-$760K	0.11%	112
2015 Q2	$1.07M	Sell	19,742 -1,205	-6%	-$67.6K	0.32%	69
2015 Q1	$1.15M	Sell	20,947 -1,007	-5%	-$57K	0.34%	68
2014 Q4	$1.19M	Sell	21,954 -562	-2%	-$31.3K	0.34%	67
2014 Q3	$1.27M	Hold	22,516	–	–	0.37%	65
2014 Q2	$1.24M	Buy	22,516 +11,622	+107%	+$634K	0.36%	66
2014 Q1	$590K	Buy	10,894 +734	+7%	+$38K	0.28%	57
2013 Q4	$485K	Sell	10,160 -11,701	-54%	-$535K	0.22%	68
2013 Q3	$993K	Sell	21,861 -5,151	-19%	-$235K	0.3%	69
2013 Q2	$1.2M	Buy	+27,012	New	+$1.21M	0.61%	45

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fairfield, Bush & Co's MRK Position: Q1 2026 in Review

Fairfield, Bush & Co reduced its Merck (MRK) stake by 5.5% in Q1 2026, selling an estimated $144K and leaving 21,247 shares worth $2.56M. The position accounts for 1.42% of the portfolio, ranked #22.

Fairfield, Bush & Co first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.52M in Q3 2020. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Fairfield, Bush & Co held 21,247 shares of Merck worth $2.56M as of Q1 2026.
Fairfield, Bush & Co sold 1,247 Merck shares in Q1 2026, an estimated $144K.
Merck made up 1.42% of Fairfield, Bush & Co's portfolio in Q1 2026, its #22 holding.
Fairfield, Bush & Co first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Fairfield, Bush & Co's Merck position peaked at $3.52M in Q3 2020.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Fairfield, Bush & Co's 13F filing for Q1 2026, filed 12 May 2026.